TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
X Dai, Z Wu, R Ruan, J Chen, C Huang, W Lei… - Cell Communication and …, 2024 - Springer
Background The effectiveness of anti-programmed cell death protein 1 (PD-1)/programmed
cell death 1 ligand 1 (PD-L1) therapy in treating certain types of cancer is associated with …
cell death 1 ligand 1 (PD-L1) therapy in treating certain types of cancer is associated with …